logo-loader
viewMarrone Bio Innovations

Full interview: Marrone Bio Innovations performing well in all areas with strong 2Q results

Marrone Bio Innovations Inc (NASDAQ:MBII) CFO Jim Boyd tells Proactive the sustainable bio-protection and plant health solutions company posted strong second quarter results, and explains how its been performing well in all areas.

In addition, Boyd says the California-based company has revealed a new agricultural technology acquisition, together with a $36.6 million financing facility with existing investors to help fund it.

Quick facts: Marrone Bio Innovations

Price: 1.23 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $171.35 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations receives approval from EPA for...

Marrone Bio Innovations (NASDAQ: MBII) CEO and Founder Dr Pam Marrone joined Steve Darling from Proactive Vancouver on Skype with news that two of its biofungicide products Stargus and Regalia have been approved by the U.S. Environmental Protection Agency for indoor and outdoor use on hemp...

on 01/07/2020

2 min read